Growing evidence suggests that the key to treating Alzheimer's is catching it in its earliest stages. Now scientists have ...

A nationwide clinical trial is testing whether an existing drug could benefit patients with Alzheimer's disease, in hopes of making symptom-improving medication more accessible for people experiencing ...

Researchers showed that a severe drop in NAD+—a core energy molecule—drives Alzheimer’s pathology in both human brains and mouse models.

Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate ...

UT Health San Antonio's Center for Brain Health will bring together clinician expertise in dozens of disorders. The facility will participate in national research initiatives, focusing on clinical ...

Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...

A team of investigators looked at possible dementia clinical trial requirements that could exclude people based on race and ethnicity. Overall, 82% of the trials they examined had criteria that ...

Alzheimer's disease, the most common form of dementia, is responsible for tens of millions of cases around the world. Jens Kalaene/dpa Following tests on apes and mice, a team of University of New ...

Alzheimer's researchers believe a cure for the brain disease could be closer than many think. Researchers at the University ...

Nearly one million people in the UK are estimated to have dementia, the UK’s biggest killer. Yet, dementia research progress is stalling as dementia clinical trials struggle to recruit. In 2023/24 ...

In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called ...

For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease ...